Imaging plaque biology in patients with asymptomatic carotid artery stenosis
Official title: PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With Cu[64]-25%-CANF-Comb-II
Run by Washington University School of Medicine · NCT05838547 · Data updated 2026-11-12
This study is testing a new imaging method to see how plaque in the carotid arteries affects the risk of strokes in people who have narrowing of these arteries but don’t have any symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Status | Recruiting |
| Started | March 21, 2023 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT05838547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with asymptomatic carotid artery stenosis of 60% or greater as confirmed by imaging.
✕Probably not a fit
Patients with a recent history of stroke or TIA, or those unable to comply with study procedures, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate plaque biology in patients with asymptomatic carotid artery stenosis (ACAS) using advanced imaging techniques. Participants will undergo a carotid PET-MRI examination after receiving an intravenous injection of a radiotracer, 64Cu-CANF-Comb, to assess its uptake and correlate it with patient outcomes such as stroke or transient ischemic attack. The study will include 80 subjects and is designed to enhance understanding of the role of Natriuretic Peptide Receptor C in carotid atherosclerosis progression. The findings could help in risk stratification for stroke events in ACAS patients.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients with asymptomatic carotid artery stenosis.
How similar studies have gone: Previous studies have shown promising results with similar imaging approaches, indicating potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults, 18 years of age or older * Asymptomatic carotid artery stenosis patients who have undergone carotid Doppler/ultrasound imaging or other carotid imaging which have demonstrated a ≥ 60% diameter carotid artery stenosis. * The treating surgeon has planned either treatment with optimal medical therapy (OMT) alone, or OMT and carotid endarterectomy (CEA) surgical intervention. Exclusion Criteria: * Inability to receive and sign informed consent. * Patients with an unstable clinical condition that in the opinion of the Sponsor-Investigator or designee precludes participation in the study. * Inability to tolerate up to 60 minutes in a supine position with arms down at sides for PET-MR imaging. * Prior history of CEA or carotid artery stent procedure on the ipsilateral side. * Past medical history of TIA or stroke within the last 6 months. * Unwilling to comply with study procedures and/or unable to be available for the duration of the study outlined in the protocol. * Contraindications to MR imaging (pacemaker, brain aneurysm clips, shrapnel, claustrophobia, etc.). * Currently pregnant or lactating. All female subjects of childbearing potential must have a documented negative pregnancy test (serum or urine hCG) performed within 24 hours immediately prior to the administration of 64Cu-25%-CANF-Comb or documented post-menopausal defined as the cessation of menses for ≥ 12 months or documentation of having a bilateral oophorectomy and/or hysterectomy.
Where it's running
-
Cedars Sinai Medical Center
Los Angeles, California, United States Recruiting -
Washington University in St. Louis
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Pamela Woodard, MD — Washington University School of Medicine
- Study coordinator: Molly Mohrman
- Email: mohrmanm@wustl.edu
- Phone: 314-747-4633
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Photon-counting CT vs conventional CT for carotid plaque in people with carotid artery stenosis
This study tests whether photon-counting CT gives clearer, more detailed pictures of carotid plaques compared with standard CT in patients with carotid artery stenosis to help characterize plaque features.
-
3D contrast-enhanced microvascular ultrasound to detect new blood vessel growth in carotid plaques
This test tries to see if 3D contrast-enhanced ultrasound can detect tiny new blood vessels inside carotid artery plaques in adults who previously had carotid CEUS.
-
Evaluating endovascular treatment for asymptomatic carotid artery stenosis
This study is testing if a new stenting procedure combined with medication can help people with severe carotid artery narrowing who don’t have symptoms, compared to just taking medication alone.
-
Comparing enteric-coated and plain aspirin to reduce heart disease risks from air pollution
This study is testing whether enteric-coated or plain low-dose aspirin can better help people with heart disease reduce their risks from air pollution, along with providing tips to stay healthy.
-
Carotid artery stenting during treatment of acute stroke
This study is testing if adding carotid artery stenting during a stroke treatment can help improve blood flow to the brain and lower the chances of having another stroke for patients with blocked carotid arteries.
-
Exploring the link between carotid atherosclerosis and coronary artery disease
This study looks at whether the buildup of plaque in the neck arteries is linked to heart artery disease in patients who have chest pain or tightness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.